Equity Overview
Price & Market Data
Price: $0.893
Daily Change: +$0.0126 / 1.41%
Range: $0.875 - $0.895
Market Cap: $54,421,108
Volume: 346,630
Performance Metrics
1 Week: 2.36%
1 Month: 23.12%
3 Months: -5.04%
6 Months: -14.99%
1 Year: -22.38%
YTD: -6.04%
Company Details
Employees: 10
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule therapeutics to treat cancer and other serious diseases in the United States. It is developing KB-9558, a p300 KAT inhibitor development candidate which is in preclinical development for the treatment of multiple myeloma, as well as HPV-driven tumors; and KB-7898, a p300 KAT inhibitor, which is in preclinical development for the treatment of Sjogren's disease. The company was incorporated in 2017 and is headquartered in San Mateo, California.